Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Stock indices provide benchmarks and a lens into market trends. This overview explains their purpose and how investors leverage them.
16,698 articlesDanish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Tech stocks wobbled Friday as yields spiked, triggering a risk-off pullback. This piece lays out where to position wh...
Microsoft stands at the crossroads of cloud infrastructure and productivity software, offering a durable growth thesi...
The market has been pushing toward higher rates, and the phrase uh-oh! probability fomc rate is popping up in convers...
A rising pushback against data centers is reshaping the debate over AI infrastructure. This article breaks down what ...
CNBS traders are weighing a high-conviction cannabis theme against a thin dividend base. The ETF leans on one rent-pr...
SpaceX surged after an overnight price spike sees the rocket maker leapfrog Amazon to fifth-largest U.S. company by m...
SpaceX's IPO debut has turned into a high-velocity, meme-like run as investors chase a limited float. Crypto-linked f...
Two popular international ETFs, ishares' URTH and Schwab's SCHF, sit at the center of many portfolios. This guide bre...
China’s domestic auto market is feeling the squeeze even as exporters push ahead. Nio sits at a crossroads where poli...
Bitcoin ETFs posted a sixth consecutive week of outflows as Franklin Templeton filed two new ETF proposals. Market wa...
Choosing between SCHD and VIG comes down to your goals: current income vs. steady growth. This guide breaks down how ...